Clinical Pharmacokinetics of Paclitaxel
- 1 October 1994
- journal article
- clinical trial
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 27 (4) , 256-269
- https://doi.org/10.2165/00003088-199427040-00002
Abstract
Paclitaxel is a new anticancer agent showing significant promise as therapy for solid tumours and leukaemia, given alone or in combination with other chemotherapeutic agents. Paclitaxel...Keywords
This publication has 43 references indexed in Scilit:
- Saturable pharmacokinetics and paclitaxel pharmacodynamics in children with solid tumors.Journal of Clinical Oncology, 1994
- Paclitaxel: what schedule? What dose?Journal of Clinical Oncology, 1994
- Pharmacokinetics of Taxol and Doxorubicin Administered Alone and in Combination by Continuous 72-Hour InfusionJNCI Journal of the National Cancer Institute, 1994
- Taxol in combination with doxorubicin or etoposide possible antagonism in vitroCancer, 1993
- Sequences of taxol and cisplatin: a phase I and pharmacologic study.Journal of Clinical Oncology, 1991
- Taxol: A Novel Investigational Antimicrotubule AgentJNCI Journal of the National Cancer Institute, 1990
- PHASE-I AND PHARMACODYNAMIC STUDY OF TAXOL IN REFRACTORY ACUTE LEUKEMIAS1989
- PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF TAXOL1987
- HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR TAXOL IN HUMAN-PLASMA AND URINE AND PHARMACOKINETICS IN A PHASE-I TRIAL1987
- Structure-activity study of cytotoxicity and microtubule assembly in vitro by taxol and related taxanesBiochemical and Biophysical Research Communications, 1982